158 related articles for article (PubMed ID: 1254407)
1. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
2. Ara AMP- a highly soluble new antiviral drug.
Pavan-Langston D; North RD; Geary PA
Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
4. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
5. Adenine arabinoside in the management of herpetic keratitis.
McGill JI; Coster D; Frauenfelder T; Holt-Wilson AD; Williams H; Jones BR
Trans Ophthalmol Soc U K (1962); 1975 Jul; 95(2):246-9. PubMed ID: 818752
[TBL] [Abstract][Full Text] [Related]
6. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.
Kwon BS; Gangarosa LP; Park NH; Hull DS; Fineberg E; Wiggins C; Hill JM
Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030
[TBL] [Abstract][Full Text] [Related]
7. [The virostatic effect of adenine-arabinoside monophosphate. Experimental findings and preliminary clinical experiences].
Werner GT; Bömer H; Metzger E; Sauer O; Schneider H; Schubert E; Treuner J
Fortschr Med; 1978 Aug; 96(32):1589-97. PubMed ID: 680620
[TBL] [Abstract][Full Text] [Related]
8. Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A).
Ch'ien LT; Whitley RJ; Nahmias AJ; Lewin EB; Linnemann CC; Frenkel LD; Bellanti JA; Buchanan RA; Alford DA
Pediatrics; 1975 May; 55(5):678-85. PubMed ID: 165453
[TBL] [Abstract][Full Text] [Related]
9. [Arabinosyladenine in ophthalmology (author's transl)].
Colin J
J Fr Ophtalmol; 1981; 4(6-7):525-30. PubMed ID: 7028853
[TBL] [Abstract][Full Text] [Related]
10. Ara-A and IDU therapy of human superficial herpetic keratitis.
Laibson PR; Hyndiuk R; Krachmer JH; Schultz RO
Invest Ophthalmol; 1975 Oct; 14(10):762-3. PubMed ID: 1102484
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary clinical experiences with adenine arabinoside monophosphate (ARA-AMP) in encephalitis due to viruses of the herpes group and varicella/zoster infections (author's transl)].
Sauer O; Werner GT; Schneider H; Lenard HG; von Haselberg L; Nettesheim HJ
Klin Padiatr; 1979 Nov; 191(6):566-71. PubMed ID: 92592
[TBL] [Abstract][Full Text] [Related]
12. Ocular and systemic antiviral activity of vidarabine.
Pavan-Langston D; Hess F
Compr Ther; 1977 Jul; 3(7):42-8. PubMed ID: 195767
[No Abstract] [Full Text] [Related]
13. [Adenine-arabinoside in the treatment of idu-resistant herpes simplex keratitis (author's transl)].
Colin J; Baikoff G; Chastel C; Renard G
J Fr Ophtalmol; 1979 Mar; 2(3):205-7. PubMed ID: 156754
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex keratitis: animal models to guide the selection and optimal delivery of antiviral chemotherapy.
Falcon MG; Jones BR
J Antimicrob Chemother; 1977 Mar; 3 Suppl A():83-9. PubMed ID: 863807
[No Abstract] [Full Text] [Related]
15. Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus.
Coster DJ; McKinnon JR; McGill JI; Jones BR; Fraunfelder FT
J Infect Dis; 1976 Jun; 133 Suppl():A173-7. PubMed ID: 819598
[TBL] [Abstract][Full Text] [Related]
16. Adenine arabinoside in idoxuridine unresponsive and intolerant herpetic keratitis.
Hyndiuk RA; Hull DS; Schultz RO; Chin GN
Am J Ophthalmol; 1975 Apr; 79(4):655-8. PubMed ID: 123413
[TBL] [Abstract][Full Text] [Related]
17. Effect of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on experimental herpes simplex keratitis.
Kaufman HE; Varnell ED
Antimicrob Agents Chemother; 1976 Dec; 10(6):885-8. PubMed ID: 1008546
[TBL] [Abstract][Full Text] [Related]
18. Intraocular penetration of the soluble antiviral, Ara AMP.
Pavan-Langston D; North RD; Geary PA; Kinkel A
Arch Ophthalmol; 1976 Sep; 94(9):1585-8. PubMed ID: 962668
[TBL] [Abstract][Full Text] [Related]
19. Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.
Sidwell RW; Allen LB; Huffman JH; Revankar GR; Robins RK; Tolman RL
Antimicrob Agents Chemother; 1975 Oct; 8(4):463-7. PubMed ID: 1190753
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of adenine arabinoside and idoxuridine in the treatment of ocular herpes simplex.
Pavan-Langston D
Am J Ophthalmol; 1975 Sep; 80(3 Pt 2):495-502. PubMed ID: 1099915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
